HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Studies of the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one in thalassemia patients.

AuthorsN F Olivieri, G Koren, P St Louis, M H Freedman, R A McClelland, D M Templeton
JournalSeminars in hematology (Semin Hematol) Vol. 27 Issue 2 Pg. 101-4 (Apr 1990) ISSN: 0037-1963 [Print] United States
PMID2190316 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Iron Chelating Agents
  • Pyridones
  • Deferiprone
  • Iron
  • Deferoxamine
Topics
  • Administration, Oral
  • Adolescent
  • Adult
  • Chelation Therapy (methods)
  • Child
  • Deferiprone
  • Deferoxamine (therapeutic use)
  • Drug Administration Schedule
  • Humans
  • Iron (urine)
  • Iron Chelating Agents (therapeutic use)
  • Pilot Projects
  • Pyridones (therapeutic use)
  • Randomized Controlled Trials as Topic
  • Thalassemia (therapy, urine)
  • Transfusion Reaction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: